ArticleJournal of arthropod-borne diseases2025
Prevalence and Susceptibility Status of Body Louse (
Article in Journal of arthropod-borne diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The body louse spreads diseases such as epidemic typhus and louse-borne relapsing fever and has shown resistance to various insecticides. While deltamethrin is used to treat infestations in some countries, research on its effectiveness against body lice is limited. This study assessed the susceptibility of body lice to deltamethrin using a bioassay. Methods: Body lice specimens were collected from an addiction treatment camp in Urmia City, West Azerbaijan Province, Iran. They were treated in 5 cm Petri dishes lined with 1 ml of various concentrations of deltamethrin (0.01, 0.02, 0.04, 0.08, 0.16, 0.32, 0.64, 1.28, and 2.56 ppm) in acetone. Thirty lice were tested per concentration, with mortality recorded after 24 hours. Lethal concentrations of 50% and 90% (LC Results: A positive correlation was observed between the concentrations of deltamethrin and probit mortality in the regression analysis. The calculated LC Conclusions: These findings suggest that the body lice population was susceptible to deltamethrin, suggesting its potential as an alternative treatment, pending further clinical studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.